Pinealon

Research Applications

• Neuroscience: Pinealon (Glu-Asp-Arg) is studied as a bioregulatory tripeptide targeting the central nervous system and pineal gland function. Research from the Khavinson program demonstrates its ability to modulate gene expression in neural tissue, protect neurons against oxidative stress and hypoxia, and support cognitive function in aging brain models. Studies examine the molecular mechanisms by which this minimal three-amino-acid sequence achieves organ-specific neurological effects.
• Chronobiology: Pinealon is studied for its effects on pineal gland function and melatonin synthesis regulation. Research examines its ability to restore age-related melatonin decline, normalize circadian rhythm disruption, and improve sleep-wake cycle regulation. Studies investigate the gene-expression-level mechanisms of pineal gland regulation and the downstream neuroendocrine consequences of restored melatonin production.
• Gerontology: Pinealon is studied in aging research for its neuroprotective effects against age-related cognitive decline. Research examines its ability to maintain neuronal viability, preserve synaptic density, and protect against oxidative and hypoxic damage in aged brain tissue models. Studies compare Pinealon's neuroprotective efficacy against other bioregulatory peptides and conventional neuroprotective agents.
• Bioregulator Science: Pinealon serves as a model compound for studying how minimal peptide sequences (as short as 2-3 amino acids) can achieve organ-specific biological effects. Research examines the mechanisms of peptide-DNA interaction, tissue-specific gene expression modulation, and the structural features that determine organ targeting by short bioregulatory peptides in the Khavinson research paradigm.